To treat ocular conditions or regain normal eye function, ophthalmic eye drops are used to deliver medications locally in the ocular cavities. Topical instillation of eye drops is the most popular and straightforward method of ocular drug administration, and it serves as the preferred course of treatment. Globally, it is anticipated that eye infections will become more …
Category Archives: Healthcare Trends
Peptide Receptor Radionuclide Therapy (PRRT) Market is expected to reach a valuation of US$ 1,106.50 Million by 2032 | FMI Analyst
During the forecast period, the Peptide Receptor Radionuclide Therapy (PRRT) Market is expected to grow at a strong CAGR of 7.2%. The market is currently worth US$ 552.08 million in 2022 and is expected to grow to US$ 1,106.50 million by 2032. This Peptide Receptor Radionuclide Therapy market study offers a comprehensive analysis of the business models, key strategies, …
North America is anticipated to hold 37.0% of the Atherosclerosis market in the assessment period 2022 to 2032 | FMI
The Atherosclerosis Market is expected to be worth US$ 58,236.4 Million by 2032, growing at a CAGR of 2.8% between 2022 and 2032, from a current value of US$ 44,183.8 Million in 2022. The rising prevalence of cardiovascular diseases is a significant factor driving market growth. Atherosclerosis is the narrowing of the vein as a result of …
Ambulatory Polysomnography (PSG) Systems Market is anticipated to reach US$ 516.9 million by 2032, at a CAGR of 5.2% | FMI
The global Ambulatory Polysomnography (PSG) Systems Market is estimated to be worth US$ 311.2 million in 2022 and to grow at a CAGR of 5.2% to be worth US$ 516.9 million by 2032. According to a recent Future Market Insights analysis, up to 24 channel PSG systems in the product sector would dominate the market …
Softgel Capsules Market is estimated to reach US$ 1.9 billion by 2032, with a 6.0% CAGR | FMI Reports
The global Softgel Capsules Market is anticipated to create robust growth opportunities by registering a CAGR of 6.0% from 2022 to 2032. The global market enjoyed a valuation of US$ 1.1 Billion by the end of the year 2022 to surpass a valuation of US$ 1.9 Billion by the year 2032. According to a recent …
Freeze Drying Market is estimated to reach US$ 2.5 billion by 2032, at an 8.5% CAGR | FMI Study
According to Future Market Insights’ most recent industry analysis, the worldwide Freeze Drying Market was valued at roughly US$ 1.0 Billion in 2021 and is likely to expand at a CAGR close to 8.5% over the forecast period, with an estimated worth of approximately US$ 2.5 Billion in 2032. Freeze drying often referred to as …
Neurology Clinical Trials Market in the United States is expected to be worth US$ 3.7 billion by 2032 | FMI
In 2021, the global Neurology Clinical Trials Market was estimated to be worth approximately US$ 5.4 billion. With a CAGR of 6.3% over the next ten years, the market is expected to be worth nearly US$ 10.5 billion by the end of 2032. Over the forecasted period, the neurology clinical trials market is expected to …
Direct Oral Anticoagulants Market share is anticipated to reach US$ 71.78 Billion by 2032
The direct oral anticoagulants market is expected to grow at a 7.5% CAGR during the forecast period, reaching a market share of US$ 71.78 Billion in 2032, up from US$ 24.26 Billion in 2021, owing to increased FDA and CE mark approval for direct oral anticoagulants. As per comprehensive research conducted by ESOMAR-certified consulting firm …
Multiple Myeloma Diagnostics Market is projected to reach US$ 32.91 billion by 2032
During the forecast period, the multiple myeloma diagnostics market is expected to grow at a promising CAGR of 10.3%. The market is currently worth US$ 13.62 billion and is expected to grow to US$ 32.91 billion by 2032. Multiple plasma cells aid in the fight against numerous illnesses, however the accumulation of malignant plasma cells …
Airway Disease Treatment Market is set to advance at a CAGR of 5.2% 2022 to 2032
The globalairway disease treatment market is projected to amass a revenue of around US$ 3,495.3 million by 2032, up from US$ 1,996.1 million in 2022 moving forward with a CAGR of 5.2% during the forecast period. LABA-ICS, LAMA-ICS, triple treatment, and other related drugs are among the pharmaceuticals used in combination therapy for COPD. Combination therapy is gaining popularity due to its …
Continue reading “Airway Disease Treatment Market is set to advance at a CAGR of 5.2% 2022 to 2032”